Search
Now showing items 1-2 of 2
Pharmacoeconomic Evaluations of Oral Anticancer Agents. Thematic Systematic Review
(
Hamad bin Khalifa University Press (HBKU Press)
, 2014 , Conference Paper)
Background: Around 14.1 million new cancer cases and 8.2 million deaths caused by cancer were reported in 2012, expected to rise up to 22 million within the next 2 decades. The parenteral route (intravenous dosage form) ...
Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital
(
SAGE
, 2023 , Article)
Background: The economic benefit of the clinical pharmacist's role in ensuring the optimum use of medicines is potentially considerable, particularly when it comes to cancer management. We sought to evaluate the overall ...